Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 22, 2015 11:25 PM ET

Biotechnology

Company Overview of Rigel Pharmaceuticals, Inc.

Executive Profile

Donald G. Payan M.D.

Co-Founder, President of Discovery & Research, Executive Vice President and Director, Rigel Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 3 different industries.

See Board Relationships
65$1,353,767
As of Fiscal Year 2014

Background

Dr. Donald G. Payan, M.D. is a Co-Founder of Rigel Pharmaceuticals, Inc. and has been its Executive Vice President since January 1997. Dr. Payan has been President of Discovery and Research at Rigel Pharmaceuticals, Inc. since February 2008. He served as the Chief Scientific Officer of Rigel Pharmaceuticals, Inc. since January 1997. He served as President and Chief Executive Officer of Rigel Pharmaceuticals, Inc. from July 1996 to January 1997 and also served as its ...

Corporate Headquarters

1180 Veterans Boulevard
South San Francisco, California 94080

United States

Phone: 650-624-1100
Fax: 650-624-1101

Board Members Memberships

Former Director
1996-Present
Co-Founder, President of Discovery & Research, Executive Vice President and Director

Education

BS
Stanford University
MD
Stanford University

Other Affiliations

Annual Compensation

Salary$559,571
Total Annual Compensation$559,571

Stocks Options

All Other Compensation$9,906
Exercisable Options$1,180,291
Unexercisable Options$273,959
Total Number of Options$1,454,250

Total Compensation

Total Annual Cash Compensation$569,477
Total Short Term Compensation$559,571
Other Long Term Compensation$9,906
Total Calculated Compensation$1,353,767
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Paolo Pucci Chief Executive Officer and Director
ArQule Inc.
$489.3K
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
$1.3M
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
$755.2K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$555.7K
Myung-Joong Cho Ph.D.Founder, Chief Executive Officer and President
CrystalGenomics, Inc.
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Rigel Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.